Finally, in order to demonstrate that MBZ was able to inhibit MAPK14 activity in live GBM cells, we conducted NanoBRETTM target engagement intracellular kinase assay in U87 cells transfected with MAPK14‐NanoLuc® fusion vector DNA. Here, MAPK14 is linked to glioblastoma.